[ad_1] NEW YORK, Sept. 3, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of The Chemours Company (“Chemours” or the “Company”) (NYSE: CC). Such investors are advised to contact Danielle Peyton at [email protected] or […]

[ad_1] NEW YORK, Sept. 3, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of  Metagenomi, Inc. (“Metagenomi” or the “Company”) (NASDAQ: MGX).  Such investors are advised to contact Danielle Peyton at [email protected] or […]

[ad_1] NEW YORK, Sept. 3, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of W. P. Carey Inc. (“W. P. Carey” or the “Company”) (NYSE: WPC).  Such investors are advised to […]

[ad_1] NEW YORK, Sept. 3, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of AvidXchange Holdings, Inc. (“AvidXchange” or the “Company”) (NASDAQ: AVDX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, […]

[ad_1] NEW YORK, Sept. 3, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of  Arhaus, Inc. (“Arhaus” or the “Company”) (NASDAQ: ARHS).  Such investors are advised to contact Danielle Peyton at [email protected] or […]